chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient began experiencing back pain on March 14 and on or around March 18 he started coughing up blood clots according to a coworker.  Patient lived alone and was unable to be reached on Sunday March 21.  I went over to his house and found him deceased in his bed.  Patient had a trashcan beside his bed and it appeared to have some blood in it. Patient had thick mucus coming out of his mouth and blood coming out of his nose.  According to paramedics he had passed a few hours before finding him.  Unfortunately Patient has been cremated so there is no way to say that this was related to the Covid 19 shot from Johnson and Johnson, however there are new reports that blood clots have been a side effect. I would like to speak with someone from the Department of Health to discuss this further.  I feel this could be related to the vaccination and I would to know how long the Health Department knew about this possible side effect.  If patient would have known sooner that the blood clots were a side effect I feel he would have gone to the Emergency Room.  Patient had no health insurance and he was trying to prevent getting Covid.   This has caused our family so much heartache and we are all very apprehensive about getting the Covid Vaccine ourselves.  Please contact me as soon as possible, I am also patient's  executor so I am able to speak to you on behalf of patient and our family. Thank you.
pt recv vax in 1996 & subsequently pt lab tests revealed lack of seroconversion
Two weeks after receiving my second Moderna shot I started noticing itchy red blisters appearing on my left arm. Over the next couple of days, it spread to both my arms, legs, and torso. A little later I noticed them on my bottocks. Blisters were extremely itchy and would bleed if scratched. Sometimes I would wake up to bloody sheets because of unintentional scratching at night.   I visited my primary care doctor and she had some blood work done. It didn't reveal anything serious, just some inflammation. She referred me to a dermatologist who conducted a punch biopsy. The results showed that I have spongiotic dermatitis as a result of the vaccine. I was prescribed 3 weeks of doxycycline and it did help to get the bumps to disappear. I still have some residual marks left from all the blisters and get some rash from time to time but it is not as bad.
Sharp, radiating pain from injection site to the hand. Jolts of pain occured about every 10 to 15 minutes for 10 hours. Could not be relieved. Once the stabbing pain subsided could not lift/use arm for 2 days followed by 3 days of arm weakness and throbbing pain.  All pain resolved one week post injection.
This spontaneous report as received from a physician refers to a 26 year old male patient with asthma, anxiety and penicillin allergy. On 09-JAN-2015 and 11-MAR-2015, the patient was vaccinated with respectively with the first second dose of (Oka/Merck) VARIVAX (lot #, expiration date, dose and route were not provided) and with MMR II (lot #, expiration date, dose and route were not provided). Concomitant therapies included ATIVAN. On 30-JUN-2015, the patient's antibody titers to measles, mumps, rubella and varicella were negative. The outcome of varicella virus test negative, mumps antibody test negative, rubella antibody negative and measles antibody negative was unknown. The causality between the events and (Oka/Merck) VARIVAX and MMR II was not provided. This is one of several reports from the same source. Additional information has been requested.
Menstruated for around 13 to 14 days. I've never had a cycle last over 7 days. My period is usually between 5 and 6 days.
01/03/03 at 4:15 pm, developed hives all over arms and neck. Took two of Benadryl. Hives/Rash was gone by 01/04/04 in am.
Left deltoid red, warm, tender, indurated, no cellulitis. Augmentin 400/5 1 tsp po BID for 10 days.
Immediately my left arm swelled even around and under my arm pit. Became dizzy and disoriented feverish and aching terribly all over ,it was the booster shot. In bed for about 2 weeks lethargic and aching. Went to my doctor
Injection site pain (mainly day 2) Body aches starting 3 hours after shot, worse following 2 days, but ongoing.  Some numbness, and pain.
Patient came back to the pharmacy with redness/swelling/fever in her right arm. There was a red line going around her arm near injection site.
Information has been received from a vaccine coordinator referring to unspecified patients. The patients' concurrent condition and medical history were not reported. Concomitant medication was not provided. On an unknown date, the patients were vaccinated with improperly stored doses of PROQUAD (dose, unit, route unknown, lot # M006103, expiration date 01-AUG-2017) once. No adverse event was reported. No product quality issue involved. Additional information has been requested. This is one of several reports received from the same reporter.
This spontaneous report as received from a consumer refers to her daughter - a female patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On unknown dates, the patient was vaccinated with her first and second dose of GARDASIL 9, intramuscularly (does, lot # and expiration date were not reported). In June 2016, the patient was supposed to receive her third dose of GARDASIL 9 but she missed it. There was no adverse effect reported. Additional information has been requested.
Pt received 2nd COVID vaccination at 1108. Pt reported feeling unwell, reporting that she felt her heart was racing, dry mouth, and that she was starting to see the room go dark) about 20 minutes after vaccination. Once in observation area, pt vitals were taken @1124 BP 155/89 HR 125 RR 20 O2 sat 97% on room air, pt was alert, color within normal limits, conversant and tolerating water well. @11:27 Vitals repeated, BP 145/86, HR 114 RR 18 O2 sat 97% room air.  Pt reported mild nausea and advised to no longer drink water and provided with alcohol swabs to smell.  After a few minutes pt stated she was feeling better and vitals were improving. @1133 Vitals repeated BP 126/65, HR 99, RR 17, O2 sat 98% and @11:42 128/79 HR 79 RR 16 O2 sat 99%. Pt initially declined calling ambulance transport for further evaluation; therefore, the importance of followup with PCP (message sent @11:29) and symptoms that would warrant a visit to ED were discussed and understanding verbalized.  While waiting for family to arrive to take pt home, her symptoms returned once again.  Pt stated that she felt a sensation of blood rushing from her legs, felt her face warm and flushed, her hands cold and that her heart was racing again. Chicago Medics called @11:51 to respond for patient evaluation and transport to hospital for further evaluation. Vitals @11:56 137/83 HR 109 RR 17 O2 sat 98% . Medics arrival (unit 69) @1200 and pt agreed/requested to be evaluated and transported to hospital. Pt first assisted to restroom via wheelchair and then taken to ambulance. Pt was able to use restroom without assistance or worsening of s/s. As per unit 69 medics, pt will be transported for further evaluation. Pt departed facility @12:08
Patient came on 07/14  for well check visit and received one dose of DTap. father reports patient presented with a rash on his cheeks, chest, abdomen and extremities. This was associated with fever 102 C. Dad gave tylenol and zyrtec and rash resolved. Patient presented with this evanescence rash and fever for the next 3 days. Dad kept giving him tylenol and zyrtec. Patient on Sunday presented with the same symptoms but didn't  resolve after getting tylenol so father decided to take him to the ED. Patient didn't present with wheezing, tongue swelling, angioedema, dyspnea, hypotension, or alteration in his behavior. Patient didn't present with rash/fever yesterday. As for today, patient with no symptoms.   Father reports patient presented with same symptoms in 2018 when he got the same vaccine (DTap, Hib, Polio, Pneumoccal). Was referred to allergy in city but appointment canceled after pandemic started.
sore arm; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 043L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Rheumatoid arthritis (Atypical rheumatoid arthritis), Degenerative disc disease (Degenerative disc disease in spine), Hyperglycemia (hyperglycemia pre-diabetes), Depression, GERD, Osteoarthritis and Major depression. Concomitant products included LAMOTRIGINE (LAMICTAL) for Affective disorder, METFORMIN for Hyperglycemia, AMLODIPINE, LISINOPRIL and ATENOLOL for Hypertension, DULOXETINE for Pain, LEFLUNOMIDE (ARAVA) for Rheumatoid arthritis, ATENOLOL (TENOLOL), PREGABALIN and OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm). On 25-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications provided by the reporter. Patient took 3rd dose on 10Sep2021 (lot number: 024C21A), right arm. Allergies:CT Contrast Media   This case was linked to MOD-2021-395853, MOD-2021-395875, MOD-2021-395853 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Nov-2021: Follow up received on 30-NOV-2021 contains significant information which includes patient information, patient medical history, dose information and concomitant information updated.
Patient came in for 15 month WCC on 8/31/23. Already had 15 month on 7/10/23. Received HIB and Hep A vaccines at both visits in error.  Patient did not report any symptoms in the weeks following and at the 18 months WCC mom stated no concerns in development.
Vaccinator reported no visibility of wheal, and the patient had to get another intradermal shot of Jynneos.  Clinical staff were notified and another shot of intradermal was successfully administered. Patient acknowledged the process and was provided education regarding another intradermal. Patient denies any concerns or issues regarding the process. No further treatment require
around 530PM aunt & grandma reported child was set in crib began crying but spontaneously stopped crying shortly;then pt fell over backwards, eyes rolled back in head  & became listless then began fine tremor of body;
Vaccine that had been more than 30 days in the refrigerator was given to 16 patients/vaccinate past its expiration date of 10/1/21; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine that had been more than 30 days in the refrigerator was given to 16 patients/vaccinate past its expiration date of 10/1/21) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine that had been more than 30 days in the refrigerator was given to 16 patients/vaccinate past its expiration date of 10/1/21). On 11-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine that had been more than 30 days in the refrigerator was given to 16 patients/vaccinate past its expiration date of 10/1/21) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   In regards to the vial of Moderna vial Lot: 048F21A  that was received in the refrigerator on 01SEP2021 and has been used to vaccinate past its expiration date of 01OCT2021. A carton of vials in the fridge which was put in there from the freezer on 01Sep2021. Vials were used on 5-Oct-2021, 7-Oct-2021, 8-Oct-2021, 11-Oct-2021 and 12-Oct-2021. In total, 16 patients were vaccinated in these dates using 5 vials.   No concomitant medication was reported.  No treatment drug was reported.   This case was linked to MOD-2021-352843 (Patient Link).
pt recvd 3 doses of Hep B vax & had a neg titer;
Extreme drowsiness and muscle aches/weakness. Painful and swollen lymph node under injected armpit.
Information has been received from a physician concerning a 65 year old male with hypertension, cholesterol high and arthritis who on 13-DEC-2010 was vaccinated with a dose of ZOSTAVAX (Merck) in his deltoid region of right arm. On 17-DEC-2010 (AE onset day was reported as "13-DEC-2010"), four days after receiving ZOSTAVAX (Merck), the patient was seen by the physician and complained of a "reaction" after the vaccine. The patient was seen for a low grade fever, muscle aches, right shoulder pain, and lastly, a tingling, slight rash and paresthesias over the next couple of days after receiving the vaccine. Physician provided photos of the patient's rash. On 17-DEC-2010, doctor gave the patient VALTREX, an antiviral medication for the treatment of the adverse events. At the time of the report, the patient had recovered from his adverse events ("date not specified, unknown how long symptoms lasted"). Additional information has been requested.
COVID arm.  Reddness, swelling, pain around injection site beginning on the 9th day after first injection.  Treated with ice.
1987 recvd heptavax for Hep B; titer was neg; then recvd series of Engerix-B dose; JUL91 titer result was still neg; given booster dose of Engerix-B was not tested again;
had the omcron covid two weeks ago; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (had the omcron covid two weeks ago) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced COVID-19 (had the omcron covid two weeks ago). At the time of the report, COVID-19 (had the omcron covid two weeks ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. The patient had the omcron COVID two weeks ago and now symptom free. No treatment information was provided.  This is a spontaneous case concerning a patient of unknown age and gender with no medical history reported, who experienced the unexpected event of COVID-19. The event occurred on Jan 2022 while the received dose of the mRNA  1273 vaccine occurred on an unknown date. At the time of report Covid-19 had resolved. The reporter did not provide any causality assessments. The benefit-risk relationship of the vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a patient of unknown age and gender with no medical history reported, who experienced the unexpected event of COVID-19. The event occurred on Jan 2022 while the received dose of the mRNA  1273 vaccine occurred on an unknown date. At the time of report Covid-19 had resolved. The reporter did not provide any causality assessments. The benefit-risk relationship of the vaccine is not affected by this report.
I had an allergic reaction to the Pfizer Covid-19 vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (173415). The reporter is the patient.  An adult patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "I had an allergic reaction to the Pfizer Covid-19 vaccine". Therapeutic measures were taken as a result of hypersensitivity.  Additional information: The patient stated had an allergic reaction to the Pfizer Covid-19 vaccine. Had to take a lot of diphenhydramine. Other medications (Including over-the-counter medications, nutritional and herbal supplements, etc), past medical history, family history and social history (Including occupational history, use of alcohol, tobacco, or recreational drugs) were reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt had low grade fever prior to vax;p/vax 30-60min later had shaking episode consisting of body tremors;no overt sz;temp is ER 104;had diarrhea 2 days later;fever lasted 3 days total;
swelling, erythema, hot to touch; expanded skin that looks like cellulitus; little itchiness; little itchiness; swelling; erythema; arm soreness; This spontaneous case was reported by a physician and describes the occurrence of   in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. N/A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMOXICILLIN from 23-Jan-2021 to an unknown date for Antibiotic level, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HYDROCHLOROTHIAZIDE ACTAVIS) for Hypertension.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Zyzal
Child developed fever with 24 hours of vaccine.  Two days after vaccine developed ataxia.  Was admitted to hospital for ataxia and had multiple febrile seizures there.  supportive care in hospital (IV fluids, cooling blanket).  Had PCR for HHV6 positive during hospital stay believed to be source for fever and ataxia.  8/24/09 Received hospital medical records for 7/20-24/2009. FINAL DX: ataxia, febrile seizure, roseola d/t hhv-6 Records reveal patient experienced fever, ataxia 4 days s/p vaccination.  Admitted for observation & rehydration.  Had self-resolving seizure lasting 1-2 min w/cyanosis.  Developed lacy erythematous rash on trunk c/w roseola.  Neuro consult done.  Slowly improved & referred to outpatient PT
dizziness; Body ache; Nausea; Chills; Sore arm; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Body aches), DIZZINESS (dizziness), PAIN (Body ache) and NAUSEA (Nausea) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), HCTZ, LISINOPRIL, SERTRALINE, SIMVASTATIN, BIMATOPROST (LUMIGAN) and DORZOLAMIDE for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and PAIN (Body aches). On 23-Feb-2021, the patient experienced DIZZINESS (dizziness), PAIN (Body ache), NAUSEA (Nausea) and CHILLS (Chills). On 10-Feb-2021, PAIN (Body aches) had resolved. On 11-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, DIZZINESS (dizziness), PAIN (Body ache), NAUSEA (Nausea) and CHILLS (Chills) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Treatment information was not provided.   This case was linked to MOD-2021-024355 (Patient Link).
Patient has been experiencing ongoing muscle pain since flu shot was administered. She called 10/1/19 approximately 1 month after getting flu shot noting she is still experiencing pain and soreness in her arm. She indicates she is a nurse and has had many flu shots before and hasn't experienced this previously. She notes she felt as though immunization administration technique was correct.
1-2hr p/vax site became red, swollen, rash & itching present;2 days later 1NOV97 swelling extended beyond shoulder to glands in neck;had erythromycin @ home, took med;swelling going down remained red & itchy & tender to touch;
Mom of pt reports started crying 2 2/12-3 hrs p/vax given; APAP given; pt had fever, mom reports anterior fontanel was bulging;
pt recv vax 9MAY96 & swollen to elbow over week-end;temp 100 10MAY96 evening x 48hrs 99-100;nl low temp, less than 98.6;
Severe body aches; chills; mild fever; severe headache; insomnia; This is a spontaneous report from a contactable consumer (patient). A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient's medical history included colitis ulcerative from an unknown date. Concomitant medication included mercaptopurine anhydrous and mesalamine taken for an unspecified indication, start and stop date were not reported. Approximately 6-8 hours following injection after the second dose patient experienced severe body aches, chills, mild fever, severe headache and insomnia on an unspecified date. Symptoms began to subside approximately 24 hours post injection. Therapeutic measures were taken as a result of events. Acetaminophen was used to relieve the symptoms. The outcome of the events was unknown.  No Follow-up attempts are possible. information about lot/batch number cannot be obtained.
rash in the injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE RASH (rash in the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash in the injection site). At the time of the report, VACCINATION SITE RASH (rash in the injection site) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment for the event includes Clobetasol.    This case was linked to US-MODERNATX, INC.-MOD-2021-034723 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-034723:Case for patent 1
Very swollen and inflamed (L) arm redness, headache Treatment: Icing or cool compress prn Benedry/liquid: Take 2 tsp every 6hrs to reduce inflammation Tylenol 650mg every 6hrs as needed